You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

RIFAMPIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Rifampin, and what generic alternatives are available?

Rifampin is a drug marketed by Chartwell Molecular, Epic Pharma Llc, Hikma, Lupin Pharms, Avet Lifesciences, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, Watson Pharms Teva, and Hikma Intl Pharms. and is included in twelve NDAs.

The generic ingredient in RIFAMPIN is isoniazid; rifampin. There are five drug master file entries for this compound. Additional details are available on the isoniazid; rifampin profile page.

Drug patent expirations by year for RIFAMPIN
Drug Prices for RIFAMPIN

See drug prices for RIFAMPIN

Recent Clinical Trials for RIFAMPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institut PasteurPhase 3
Centre Hospitalier Universitaire de CaenPhase 3
Ministry of Health, FrancePhase 3

See all RIFAMPIN clinical trials

Pharmacology for RIFAMPIN

US Patents and Regulatory Information for RIFAMPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecular RIFAMPIN rifampin CAPSULE;ORAL 065390-001 Mar 28, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lupin Pharms RIFAMPIN rifampin CAPSULE;ORAL 090034-001 Aug 21, 2013 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc RIFAMPIN rifampin CAPSULE;ORAL 064150-001 May 28, 1997 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma RIFAMPIN rifampin INJECTABLE;INJECTION 064217-001 Oct 29, 1999 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lupin Pharms RIFAMPIN rifampin CAPSULE;ORAL 090034-002 Aug 21, 2013 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma Intl Pharms RIFAMPIN AND ISONIAZID isoniazid; rifampin CAPSULE;ORAL 065221-001 Jul 29, 2005 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.